Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 10/20 | 1.00 |
| ▸ | CYP2A6 | P11509 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 4/20 | 0.56 |
| ▸ | BACE1 | P56817 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | HTR3A | P46098 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | NOS3 | P29474 | 1/20 | 0.50 |
| ▸ | NOS1 | P29475 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL22160586 | 0.97 | TAAR1 (0.95) | TAAR1CYP2A6CYP1A2HTR2ABACE1 | |
| SCHEMBL11178971 | 0.97 | TAAR1 (0.95) | TAAR1CYP2A6CYP1A2HTR2ABACE1 | |
| Bromide SCHEMBL31206930 | 0.97 | TAAR1 (0.95) | TAAR1CYP2A6CYP1A2HTR2ABACE1 | |
| Iodide SCHEMBL28805530 | 0.97 | TAAR1 (0.95) | TAAR1CYP2A6CYP1A2HTR2ABACE1 | |
| SCHEMBL9468411 | 0.93 | TAAR1 (0.86) | TAAR1CYP2A6CYP1A2HTR2ABACE1 | |
| SCHEMBL8356905 | 0.93 | TAAR1 (0.86) | TAAR1CYP2A6CYP1A2HTR2ABACE1 | |
| SCHEMBL25131498 | 0.89 | TAAR1 (0.78) | TAAR1CYP2A6CYP1A2HTR2ABACE1 | |
| SCHEMBL12788471 | 0.87 | TAAR1 (0.75) | TAAR1CYP2A6CYP1A2BACE1ALDH1A1 | |
| SCHEMBL13710873 | 0.87 | TAAR1 (0.75) | TAAR1CYP2A6CYP1A2BACE1NOS3 | |
| SCHEMBL224548 | 0.85 | TAAR1 (0.72) | TAAR1CYP2A6CYP1A2HTR2ABACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1540 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250387385-A1 | TREATMENT FOR GLOMERULAR DISEASES | ZYDUS LIFESCIENCES LIMITED (IN) | 2025-12-25 | — | — | US | claimed |
| EP-4565233-A1 | TREATMENT FOR APLASTIC ANEMIA (AA) | Zydus Lifesciences Limited (IN) | 2025-06-11 | — | — | EP | claimed |
| EP-4549616-A1 | PROCESS FOR MAKING AMINES FROM CARBONYL COMPOUNDS USING HYDROGEN HAVING LOW DEUTERIUM CONTENT PRODUCED WITH NON-FOSSIL ENERGY | BASF SE (DE) | 2025-05-07 | — | — | EP | claimed |
| EP-4539934-A1 | TREATMENT FOR GLOMERULAR DISEASES | Zydus Lifesciences Limited (IN) | 2025-04-23 | — | — | EP | claimed |
| CN-119816306-A | Treatment of Aplastic Anemia (AA) | 载度思生命科学有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119192880-A | Preparation method of archaized pigment | 江苏众立生包装科技有限公司 | 2024-12-27 | — | — | CN | claimed |
| US-20240199542-A1 | SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-06-20 | — | — | US | claimed |
| US-20240173314-A1 | TREATMENT OF SICKLE CELL ANAEMIA | ZYDUS LIFESCIENCES LTD. (IN) | 2024-05-30 | — | — | US | claimed |
| CN-117886718-B | Preparation method of high-selectivity asymmetric urea compound and asymmetric urea compound | 内蒙古工业大学 | 2024-05-24 | — | — | CN | claimed |
| CN-117886718-A | Preparation method of high-selectivity asymmetric urea compound and asymmetric urea compound | 内蒙古工业大学 | 2024-04-16 | — | — | CN | claimed |
| US-5500428-A | Furyl-substituted purines and adenosine antagonists | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1996-03-19 | — | — | US | claimed |
| US-5384170-A | Multilayer element with thermoplastic polymers of polyvinyl alcohol and olefin copolymers | NOVAMONT S.P.A. (IT) | 1995-01-24 | — | — | US | claimed |
| WO-1994024095-A1 | IMMUNOSUPPRESSIVE AGENTS | ABBOTT LABORATORIES (US) | 1994-10-27 | — | — | WO | claimed |
| US-5358851-A | Polyclonal antibody from immunizing an animal with immunogenic carrier protein conjugated to p-tolylacetic acid, then binding product to the aromatic ring of benzene or naphthalene derivatives for detection | QUANTIX SYSTEMS, L.P. (US) | 1994-10-25 | — | — | US | claimed |
| US-5300509-A | Adenosine antagonists for treating cardiovascular disorders, vasodilation | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-04-05 | — | — | US | claimed |
| EP-0544445-A2 | Furyl-substituted purines, oxazolopyrimidines and pteridines as adenosine antagonists | ZENECA LIMITED (GB) | 1993-06-02 | — | — | EP | claimed |
| EP-0495950-A1 | A LAMINATED FILM WITH A STARCHY MATRIX AND LOW PERMEABILITY AND METHODS FOR ITS PRODUCTION | NOVAMONT S.p.A. (IT) | 1992-07-29 | — | — | EP | claimed |
| WO-1992002363-A1 | A LAMINATED FILM WITH A STARCHY MATRIX AND LOW PERMEABILITY AND METHODS FOR ITS PRODUCTION | NOVAMONT S.P.A. (IT) | 1992-02-20 | — | — | WO | claimed |
| EP-0321546-A1 | IMMUNOASSAY FOR AROMATIC RING CONTAINING COMPOUNDS | PECK, Dana P. (US) | 1989-06-28 | — | — | EP | claimed |
| WO-1988009798-A1 | IMMUNOASSAY FOR AROMATIC RING CONTAINING COMPOUNDS | PECK DANA P (US) | 1988-12-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199542-A1 | SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | HPD, DDT, PPOX | TAAR1 3744/4885CYP2A6 350/4885CYP1A2 44/4885 |
| US-20250387385-A1 | TREATMENT FOR GLOMERULAR DISEASES | SSB, GRN, ALB | TAAR1 4597/4885CYP2A6 4839/4885CYP1A2 4800/4885 |
| US-20240173314-A1 | TREATMENT OF SICKLE CELL ANAEMIA | HBG1, HBB, HBG2 | TAAR1 4317/4885CYP2A6 1617/4885CYP1A2 794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.